Preclinical studies have provided proof of concept for the feasibility and efficacy of gene therapy in human systemic lupus erythematosus (SLE). Successful efforts include gene constructs that alter the expression of cytokines or limit the cognate interaction of immune cells. Other efforts may include gene modified cell transfersuch as autologousB cells transfectedwith tolerogenicconstructsor T cells in which specific molecular aberrations have been corrected.
Tsokos GC , Boumpas DT.Systemic lupus erythematosus. In Theofilopoulos A , Bona C eds. Molecular pathology of autoimmunity. Gordon and Breach, Harwood Academic Publishers , 2001: 255-281.
2.
Kammer GM , Tsokos GC.Molecular aberrations in human lupus . Mol Med Today2000; 6: 418-424 .
3.
Mackay I , Rosen F.Advances in immunology: complement, second of two parts . N Engl J Med2001; 344: 1140-1144 .
4.
Arnett FC , Reveille JD , Wilson RWet al.Systemic lupus erythematosus: current state of the genetic hypothesis . Semin Arthritis Rheum1984; 14: 24-35 .
5.
Lahita RG.The role of sex hormones in systemic lupus erythematosus . Curr Opin Rheumatol1999; 11: 352-356 .
6.
Deapen D , Escalante A , Weinrib Let al.A revised estimate of twin concordance in systemic lupus erythematosus . Arthritis Rheum1992; 35: 311-318 .
7.
Tsao BP.The genetics of human systemic lupus erythematosus . Trends Immunol2003; 24: 595-602 .
8.
Kyttaris VC , Tsokos GC.Uncovering the genetics of systemic lupus erythematosus . Am J Pharmacso2003; 3: 193-202 .
9.
Karassa FB , Bijl M , Davies KAet al.Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis . Arthritis Rheum2003; 48: 1930-1938 .
10.
Salmon JE , Millard S , Schachter LAet al.Fc gamma RIIA alleles are heritable risk for SLE nephritis in African Americans . J Clin Invest1996; 97: 1348-1354 .
11.
Edberg JC , Langfeld CD , Wu Jet al.Genetic linkage and association of Fcgr Receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus . Arthritis Rheum2002; 46: 2132-2140 .
12.
Salmon JE , Pricop L.Human receptors of immunoglobulin G: key elements in the pathogenesis of rheumatic disease . Arthritis Rheum2001; 44: 739-750 .
13.
Browness P , Davies KA , Norsworthy PJet al.Hereditary C1q deficiency and systemic lupus erythematosus . QMJ1994; 87: 455-464 .
14.
Pickering MC , Botto M , Taylor PR , Lachmann PJ , Walport MJ.Systemic lupus erythematosus, complement deficiency, and apoptosis . Adv Immunol2000; 76: 227-324 .
15.
Tsao BP , Cantor RM , Grossman Met al.PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus . J Clin Invest1999; 103: 1135-1140 .
16.
Prokunina L , Castillejo-Lopez C , Oberg Fet al.A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans . Nature Genetics2002; 32: 666-669 .
Present DH , Rutgeerts P , Targan Set al.Infliximab for the treatment of fistulas in patients with Crohn’s disease . N Engl J Med1999; 340: 1398-1405 .
Mageed RA , Prud’homme GJ.Immunopathology and the gene therapy in lupus . Gene Ther2003; 10: 861-874 .
21.
Prud’homme GJ , Kono DH , Theofilopoulos AN.Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice . Molec Immunol1995; 32: 495-503 .
22.
Prud’homme GJ , Chang Y.Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein . Gene Ther1999; 6: 771-777 .
23.
Chang Y , Prud’homme GJ.Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 fusion protein . J Gene Med1999; 1: 415-423 .
Raz E , Dudler J , Lotz Met al.Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery . Lupus1995; 4: 286-292 .
26.
Huggins ML , Huang FP , Xu D , Lindop G , Stott DI.Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier . Lupus1999; 8: 29-38 .
27.
Gutierrez-Ramos JC , Andreu JL , Revilla Y , Vinuela E , Martinez C.Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus . Nature1990; 346: 271-274 .
28.
Huang FP , Feng GJ , Lindop G , Strott DI , Liew FY.The role of interleukin 12 and nitric oxide in the development of spontaneousautoimmune disease in MRL/MP-lpr/lpr mice . J Exp Med1996; 183: 1447-1459 .
29.
Hagiwara E , Okubo T , Aoki Iet al.IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice . Cytokine2000; 12: 1035-1041 .
30.
Yasuda T , Yoshimoto T , Tsubura A , Matsuzawa A.Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice . Cell Immunol2001; 210: 77-86 .
31.
Takiguchi M , Murakami M , Nakagawa I , Saito I , Hashimoto A , Uede T.CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice . Life Sci2000; 66: 991-1001 .
32.
Wong HK , Kammer GM , Dennis G , Tsokos GC.Abnormal NF-kB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression . J Immunol1999; 163: 1682-1689 .
33.
Herndon TM , Juang Y-T , Solomou EE , Rothwell SW , Gourley MF , Tsokos GC.Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity . Clin Immunol2002; 103: 145-153 .
34.
Solomou EE , Juang Y-T , Gourley MF , Kammer GM , Tsokos GC.Molecular basis of deficient IL-2 productionin T cells from patients with systemic lupus erythematosus . J Immunol2001; 166: 4216-4222 .
35.
Tenbrock K , Juang Y-T , Gourley MF , Nambiar MP , Tsokos GC.Antisense cyclic adenosine 5’-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus . J Immunol2002; 169: 4147-4152 .
36.
Kammer GM , Perl A , Richardson BC , Tsokos GC.Abnormal T cell signal transduction in systemic lupus erythematosus . Arthritis Rheum2002; 46: 1139-1154 .
37.
Nambiar MP , Fisher CU , Warke VGet al.Reconstitution of deficient T cell receptor æ chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus . Arthritis Rheum2003; 48: 1948-1955 .
38.
Liu Z , Xu X , Hsu HCet al.CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis . J Clin Inv2003; 112: 1332-1341 .
39.
El Amine M , Melo M , Kang Y , Nguyen H , Qian J , Scott DW.Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells . J Immunol2000; 165: 5631-5636 .
40.
Zambidis ET , Barth RK , Scott DW.Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients . J Immunol1997; 158: 2174-2182 .
41.
Agarwal RK , Kang Y , Zambidis E , Scott DW , Chan CC , Caspi RR.Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis . J Clin Invest2000; 106: 245-252 .
42.
Melo ME , Qian J , El Amine Met al.Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases . J Immunol2002; 168: 4788-4795 .
